AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES by Flinn, I.W., Davids, M.S., Hillmen, P., Montillo, M., Delgado, J., Kuss, B.J., Tam, C.S., Jäger, U., Ghia, P., Stilgenbauer, S., Lustgarten, S., Weaver, D.T., Youssoufian, H., Cymbalista, F.

Get full text

EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL by Ghia, P., Flinn, I.W., Lamanna, N., Montillo, M., Illés, Á., Etienne, G., Delgado, J., Kuss, B.J., Tam, C.S., Offner, F., Bosch, F., Davids, M.S., Jäger, U., Cymbalista, F., Weaver, D.T., Lustgarten, S., Youssoufian, H., Stilgenbauer, S.

Get full text

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications by Kuss, B.J, Eyre, H.J, Lane, S.A, Nancarrow, J.K, Whitmore, S.A, Callen, D.F, Deeley, R.G, Cole, S.P.C, Willman, C.L, Kopecky, K.L, Willman, C.L, Kopecky, Kj, Wolman, S.R, Willman, C.L, Kopecky, Kj, Wolman, S.R

Get full text

ARA,a Novel ABC Transporter, Is Located at 16p13.1, Is Deleted in inv(16) Leukemias, and Is Shown To Be Expressed in Primitive Hematopoietic Precursors by Kuss, B.J, O'Neill, G.M, Eyre, H, Doggett, N.A, Callen, D.F, Davey, R.A

Get full text

Power electronic converter for the reluctance pump drive by Szymanski, B.J., Kompa, K., Michalke, N., Kuss, H., Schuffenhauer, U.

Request full text